News from the United States and around the world on topics related to mesothelioma and asbestos. Please email us at firstname.lastname@example.org if you have a news story you would like us to report on.
Researchers announce Keytruda and chemotherapy as the new standard of care for metastatic NSCLC, which could impact mesothelioma. Learn more at Mesothelioma.com.
A clinical trial is testing the efficacy of Tumor Treating electron fields with chemotherapy for pleural mesothelioma. Learn more at Mesothelioma.com.
A new flowchart developed by Tunisian researchers could help doctors diagnose pleural mesothelioma faster, giving patients a better chance of survival.
Johnson & Johnson and Rite Aid were named as defendants in a lawsuit alleging baby powder led to a woman’s mesothelioma. Read more at Mesothelioma.com.
A new clinical trial observed a novel immunohistochemical marker that can differentiate epithelioid mesothelioma from lung adenocarcinoma. Learn more at Mesothelioma.com.
European researchers are testing an aerosol chemotherapy treatment called PIPAC on peritoneal mesothelioma patients. Learn more about the novel study at Mesothelioma.com.
Since much of the vermiculite insulation produced from Libby, Montana, contains dangerous asbestos, USGS scientists created a new tool to better detect the toxin. Learn more at Mesothelioma.com.
Researchers at Massachusetts General Hospital have discovered a promising combination immunotherapy treatment for mesothelioma. Learn about the clinical trial at Mesothelioma.com.
New Jersey jury found Johnson & Johnson guilty in first asbestos talcum powder lawsuit loss, resulting in a $117 million verdict. Read about the case at Mesothelioma.com.
Johnson & Johnson lost its first asbestos talcum powder lawsuit with a $37 million verdict. Read about the case at Mesothelioma.com.Next >
Resources for Mesothelioma Patients and Their Families
- Request a Free Mesothelioma Treatment Guide
- Connect with Top Mesothelioma Doctors
- Locate the Nearest Comprehensive Cancer Center